Richard Clark (pharmacologist)
From Wikipedia, the free encyclopedia
- For people of the same name, please see Richard Clark.
As of May 5th, 2005, Richard T. Clark is the CEO and president of Merck Pharmaceutical Company. From 2003 until May 2005, he was the head of the Merck Manufacturing Division (MMD).
| Merck & Co., Inc. |
|
Corporate Directors: Lawrence Bossidy | William Bowen | Richard Clark | Johnnetta Cole | William Harrison | William Kelley | Rochelle Lazarus | Thomas Shenk | Anne Tatlock | Samuel Thier | Wendell Weeks | Peter Wendell |
|
Key products: Indinavir | Aprepitant | Alendronate | Rizatriptan | Finasteride | Montelukast | Rofecoxib | Ezetimibe/simvastatin | Ezetimibe | Simvastatin | The Merck Index | The Merck Manual |
|
Annual Revenue: $22.9 billion USD ( |
